Validation of the newly introduced Deauville score 5a for patients treated for advanced-stage classic Hodgkin lymphoma.

Leiders S, Ufton D, Kaul H, Weindler J, Rosenbrock J, Fuchs M, Dietlein M, Novak U, Fehr M, Greil R, Hertzberg M, Zijlstra JM, Fosså A, Kamper P, Molin D, Borchmann P, Kobe C, Ferdinandus J

Open source

DOI
10.1182/bloodadvances.2026019712
Published
2026 Sep 22
Container
Blood advances
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2026019712,
  title = {Validation of the newly introduced Deauville score 5a for patients treated for advanced-stage classic Hodgkin lymphoma.},
  author = {Leiders S and Ufton D and Kaul H and Weindler J and Rosenbrock J and Fuchs M and Dietlein M and Novak U and Fehr M and Greil R and Hertzberg M and Zijlstra JM and Fosså A and Kamper P and Molin D and Borchmann P and Kobe C and Ferdinandus J},
  year = {2026},
  journal = {Blood advances},
  doi = {10.1182/bloodadvances.2026019712},
  url = {https://doi.org/10.1182/bloodadvances.2026019712}
}

RIS

TY  - JOUR
TI  - Validation of the newly introduced Deauville score 5a for patients treated for advanced-stage classic Hodgkin lymphoma.
AU  - Leiders S
AU  - Ufton D
AU  - Kaul H
AU  - Weindler J
AU  - Rosenbrock J
AU  - Fuchs M
AU  - Dietlein M
AU  - Novak U
AU  - Fehr M
AU  - Greil R
AU  - Hertzberg M
AU  - Zijlstra JM
AU  - Fosså A
AU  - Kamper P
AU  - Molin D
AU  - Borchmann P
AU  - Kobe C
AU  - Ferdinandus J
PY  - 2026
JO  - Blood advances
DO  - 10.1182/bloodadvances.2026019712
UR  - https://doi.org/10.1182/bloodadvances.2026019712
ER  - 

APA

S, L., D, U., H, K., J, W., J, R., M, F., M, D., U, N., M, F., R, G., M, H., JM, Z., A, F., P, K., D, M., P, B., C, K., & J, F. (2026). Validation of the newly introduced Deauville score 5a for patients treated for advanced-stage classic Hodgkin lymphoma.. Blood advances. https://doi.org/10.1182/bloodadvances.2026019712

Source records